首页 › 淋巴瘤 › 宾夕法尼亚州 › Philadelphia
Philadelphia PA 淋巴瘤临床试验
15项针对 淋巴瘤的研究正在 Philadelphia及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
招募中观察性研究
- Children's Hospital of Philadelphia, Philadelphia
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
招募中2 期
- University of Pennsylvania, Philadelphia
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
招募中1 期
- University of Pennsylvania - Abramson Cancer Center, Philadelphia
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
招募中1/2 期
- Children's Hospital of Philadelphia-Center for Childhood Cancer Research, Philadelphia
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
招募中1 期
- The Children's Hospital of Philadelphia (CHOP), Philadelphia
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
招募中1/2 期
- Research Site, Philadelphia
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
招募中1/2 期
- Children's Hospital of Philadelphia, Philadelphia
A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
招募中1 期
- Thomas Jefferson University, Philadelphia
TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas
招募中1 期
- Hospital of the University of Pennsylvania, Philadelphia
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
招募中1/2 期
- Thomas Jefferson University, Philadelphia
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
招募中1/2 期
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Anti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoma
招募中1 期
- Children's Hospital of Philadelphia, Philadelphia
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
招募中1 期
- University of Pennsylvania, Abramson Cancer Center, Philadelphia
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
招募中观察性研究
- Saint Christopher's Hospital for Children, Philadelphia
CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL)
招募中1 期
- University of Pennsylvania - Abramson Caner Center, Philadelphia
其他城市的 淋巴瘤试验
- Houston, TX34 项研究
- Boston, MA33 项研究
- New York City, NY33 项研究
- Washington, DC23 项研究
- Baldwin Park, CA21 项研究
- Chicago, IL20 项研究
- Durham, NC17 项研究
- St. Louis, MO15 项研究
- Cleveland, OH14 项研究
- Edison, NJ12 项研究
- Atlanta, GA12 项研究
- Seattle, WA12 项研究
Philadelphia的其他研究
- 癌症（所有类型）59 项研究
- 乳腺癌56 项研究
- 非小细胞肺癌51 项研究
- 转移性癌症46 项研究
- 前列腺癌44 项研究
- 结直肠癌44 项研究
- 卵巢癌44 项研究
- 肺癌36 项研究
- 急性髓系白血病34 项研究
- 心力衰竭31 项研究
- 子宫内膜癌28 项研究
- 抑郁症26 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。